The clinical benefit of genome-wide cfDNA testing cannot be extrapolated from CVS data

Sistermans, Erik A.; Van Opstal, Diane; Bekker, Mireille N.; Pertile, Mark D.

doi:https://doi.org/10.1038/s41436-019-0689-5

The clinical benefit of genome-wide cfDNA testing cannot be extrapolated from CVS data

DSpace/Manakin Repository

The clinical benefit of genome-wide cfDNA testing cannot be extrapolated from CVS data

Sistermans, Erik A.; Van Opstal, Diane; Bekker, Mireille N.; Pertile, Mark D.

(2020) Genetics in Medicine, volume 22, issue 3, pp. 657 - 658

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Letter

DOI: https://doi.org/10.1038/s41436-019-0689-5

ISSN: 1098-3600

Publisher: Lippincott Williams & Wilkins

Note: Funding Information: M.D.P. is employed by the Victorian Clinical Genetics Services (VCGS), which is a not-for-profit provider of gw-cfDNA screening tests and derives income from these tests. VCGS has previously received funding from Illumina Inc. for a gw-cfDNA screening clinical study. M.P.D. declares no personal conflict of interest. The other authors declare no conflicts of interest. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

(Peer reviewed)